Minniti, Giuseppe <br/><br/>
Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jan 2015 
 - 109-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2014.09.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Hormones--therapeutic use<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--therapeutic use<br/>Brain Neoplasms--mortality<br/>Chemoradiotherapy--adverse effects<br/>Chemotherapy, Adjuvant--adverse effects<br/>DNA Methylation<br/>Dacarbazine--analogs & derivatives<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Glioblastoma--mortality<br/>Humans<br/>Karnofsky Performance Status<br/>Male<br/>O(6)-Methylguanine-DNA Methyltransferase--metabolism<br/>Propensity Score<br/>Radiotherapy Dosage<br/>Regression Analysis<br/>Retrospective Studies<br/>Temozolomide<br/>Time Factors<br/>Treatment Outcome